Kirkland, Canada

Ashraf Ibrahim

This inventor holds 1 USPTO granted patent. Top assignee: Thallion Pharmaceuticals Inc.. Active years: 2008.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ashraf Ibrahim

Introduction

Ashraf Ibrahim is a notable inventor based in Kirkland, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on prodrugs. His expertise and dedication to research have led to advancements that may benefit the treatment of various medical conditions.

Latest Patents

Ashraf Ibrahim holds a patent for "Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals." This invention focuses on phosphate prodrugs of a farnesylated dibenzodiazepinone, detailing the processes for their manufacture, pharmaceutical compositions that include these prodrugs, and their application in treating neoplasms. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Ashraf has been associated with Thallion Pharmaceuticals Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of pharmaceutical compounds.

Collaborations

Ashraf has collaborated with notable colleagues, including Faustinus Yeboah and James B McAlpine. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Ashraf Ibrahim's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments and therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…